» Articles » PMID: 31347010

Psychological Intervention (ConquerFear) for Treating Fear of Cancer Recurrence: Mediators and Moderators of Treatment Efficacy

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2019 Jul 27
PMID 31347010
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: ConquerFear is an efficacious intervention for fear of cancer recurrence (FCR) that demonstrated greater improvements than an attention control (relaxation training) in a randomized controlled trial. This study aimed to determine mediators and moderators of the relative treatment efficacy of ConquerFear versus relaxation.

Methods: One hundred and fifty-two cancer survivors completed 5 therapy sessions and outcome measures before and after intervention and at 6 months' follow-up. We examined theoretically relevant variables as potential mediators and moderators of treatment outcome. We hypothesized that metacognitions and intrusions would moderate and mediate the relationship between treatment group and FCR level at follow-up.

Results: Only total FCR score at baseline moderated treatment outcome. Participants with higher levels of FCR benefited more from ConquerFear relative to relaxation on the primary outcome. Changes in metacognitions and intrusive thoughts about cancer during treatment partially mediated the relationship between treatment group and FCR.

Conclusions: These results show that ConquerFear is relatively more effective than relaxation for those with overall higher levels of FCR. The mediation analyses confirmed that the most likely mechanism of treatment efficacy was the reduction in unhelpful metacognitions and intrusive thoughts during treatment, consistent with the theoretical framework underpinning ConquerFear.

Implications For Cancer Survivors: ConquerFear is a brief, effective treatment for FCR in cancer survivors with early-stage disease. The treatment works by reducing intrusive thoughts about cancer and changing beliefs about worry and is particularly helpful for people with moderate to severe FCR.

Citing Articles

Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant.

Onnekink A, Klatte D, van Hooft J, van den Berg S, van der Zwaan S, van Doorn R Mol Genet Genomic Med. 2025; 13(2):e70045.

PMID: 39936490 PMC: 11815477. DOI: 10.1002/mgg3.70045.


A chain mediation model reveals the association between metacognition and quality of life in hematologic tumor patients.

Cheng C, Zheng M, Yan F, Wu Y, Li T, Cao Z Sci Rep. 2024; 14(1):18446.

PMID: 39117715 PMC: 11310524. DOI: 10.1038/s41598-024-69027-w.


Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence.

Sinclair F, Gillanders D, Rooney N, Bonathan C, Hendry K, McLoone P Support Care Cancer. 2023; 31(12):700.

PMID: 37966674 PMC: 10651702. DOI: 10.1007/s00520-023-08179-3.


Intensity of mental health treatment of cancer-related psychopathology: the predictive role of Early Maladaptive Schemas.

de Vlaming I, Schellekens M, van der Lee M Support Care Cancer. 2023; 31(6):325.

PMID: 37154974 PMC: 10167132. DOI: 10.1007/s00520-023-07764-w.


Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental design.

Bruin J, van Rood Y, Peeters K, de Roos C, Tanious R, Portielje J Eur J Psychotraumatol. 2023; 14(2):2203427.

PMID: 37144665 PMC: 10165926. DOI: 10.1080/20008066.2023.2203427.


References
1.
Dieng M, Butow P, Costa D, Morton R, Menzies S, Mireskandari S . Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial. J Clin Oncol. 2016; 34(36):4405-4414. DOI: 10.1200/JCO.2016.68.2278. View

2.
Wells A, Cartwright-Hatton S . A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther. 2004; 42(4):385-96. DOI: 10.1016/S0005-7967(03)00147-5. View

3.
Lovibond P, LOVIBOND S . The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995; 33(3):335-43. DOI: 10.1016/0005-7967(94)00075-u. View

4.
Lichtenthal W, Corner G, Slivjak E, Roberts K, Li Y, Breitbart W . A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence. Cancer. 2017; 123(8):1424-1433. PMC: 5391320. DOI: 10.1002/cncr.30478. View

5.
Wampold B . How important are the common factors in psychotherapy? An update. World Psychiatry. 2015; 14(3):270-7. PMC: 4592639. DOI: 10.1002/wps.20238. View